NCT03311360 is a clinical trial of drug-coated balloon in Vertebral Artery Origin Stenosis, sponsored by Chinese Society of Interventional Radiology.

Who is sponsoring NCT03311360?

NCT03311360 is sponsored by Chinese Society of Interventional Radiology.

What drugs are being tested in NCT03311360?

Interventions in NCT03311360: drug-coated balloon, bare metal stent.

What condition does NCT03311360 study?

NCT03311360 studies Vertebral Artery Origin Stenosis.

Is NCT03311360 still recruiting?

NCT03311360 is currently completed. Last updated 3 August 2021.

Last reviewed 2021-08-03 · How we verify

NCT03311360

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Drug Coated Balloon Versus Stenting in Patients With Symptomatic Vertebral Artery Stenosis：an Observational Clinical Study

Completed Last updated 3 August 2021

What this trial tests

trial testing drug-coated balloon in Vertebral Artery Origin Stenosis in 95 participants. Completed in 1 October 2020.

Timeline

1 January 2018

Primary endpoint
1 February 2020

1 October 2020

Quick facts

Lead sponsor	Chinese Society of Interventional Radiology
Status	Completed
Study type	OBSERVATIONAL
Enrollment	95
Start date	1 January 2018
Primary completion	1 February 2020
Estimated completion	1 October 2020
Sites	9 locations across China

Drugs / interventions tested

drug-coated balloon
bare metal stent

Conditions studied

Vertebral Artery Origin Stenosis — all drugs for Vertebral Artery Origin Stenosis →

Sponsor

Chinese Society of Interventional Radiology

Who can join

Adults 18 to 80, any sex, with Vertebral Artery Origin Stenosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

There are two arms in our trial, DCB group, BMS group.The investigators are going to investigate the safety and efficacy of all groups at 6 months and 12 months.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of drug-coated balloon

Trials testing the same drug.

NCT07162792 — The Safety and Efficacy of New-Generation BRS vs. DCB for De Novo Large Coronary Artery Lesions: A Prospective RCT · NA · not yet recruiting
NCT07014475 — Efficacy of the Ranger Drug-Coated Balloon in Treating BTK Lesions in Patients With CLTI · not yet recruiting
NCT06104033 — Practice Change With Drug-coated Balloon in Patients With multiVessel Coronary Artery Disease · recruiting
NCT05616520 — Treatment of Complex Femoropopliteal Artery Lesions Using Drug-coated PTA Balloon · unknown
NCT05550233 — Drug-coated Balloons in Big de Novo Coronary Disease · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03311360 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Chinese Society of Interventional Radiology
Last refreshed: 3 August 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03311360.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing